Kelun-Biotech

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (Kelun Botai, HKEX: 6990), a Chengdu-based subsidiary of Sichuan Kelun Pharmaceutical (SZSE: 002422) established in 2016, is an innovative biopharmaceutical company focused on the research, development, manufacturing, and commercialization of novel drugs. It specializes in antibody-drug conjugates (ADCs) and other conjugated therapies across both large-molecule and small-molecule modalities, targeting oncology and autoimmune diseases. The company operates several core drug-discovery platforms and maintains a pipeline of 30+ candidates with multiple approved and clinical-stage programs. It was surfaced as a portfolio company of idg-capital and added to the API Evangelist network; as a pharmaceutical manufacturer it publishes no public developer or API surface.

Kelun-Biotech is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Pharmaceuticals, Biotechnology, and Oncology.

🌐 Visit website 📡 Source on GitHub

2.2/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-20 · rubric v0.12.0

0 APIs

Company Healthcare Pharmaceuticals Biotechnology Oncology Drug DevelopmentAntibody-Drug ConjugateChina

Kin Score

Kin Score How this is scored →
scored 2026-08-20 · rubric v0.12.0

Composite quality — 2.2/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 0.0 / 17

Access Clarity 0.0 / 17

Operational Transparency 0.0 / 11

Contract Governance 0.0 / 10

Discoverability 4.3 / 9

Regulatory Posture 0.0 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

Documented Reversibility 0 / 6

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/kelun-biotech: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Company 3

The organization behind the API

Website

Website

Careers

Careers

InvestorRelations

InvestorRelations

Source (apis.yml)

aid: kelun-biotech
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/kelun-biotech.png
name: Kelun-Biotech
description: 'Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (Kelun Botai, HKEX: 6990), a Chengdu-based subsidiary of Sichuan
  Kelun Pharmaceutical (SZSE: 002422) established in 2016, is an innovative biopharmaceutical company focused on the research,
  development, manufacturing, and commercialization of novel drugs. It specializes in antibody-drug conjugates (ADCs) and
  other conjugated therapies across both large-molecule and small-molecule modalities, targeting oncology and autoimmune diseases.
  The company operates several core drug-discovery platforms and maintains a pipeline of 30+ candidates with multiple approved
  and clinical-stage programs. It was surfaced as a portfolio company of idg-capital and added to the API Evangelist network;
  as a pharmaceutical manufacturer it publishes no public developer or API surface.'
url: https://raw.githubusercontent.com/api-evangelist/kelun-biotech/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- idg-capital
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Healthcare
- Pharmaceuticals
- Biotechnology
- Oncology
- Drug Development
- Antibody-Drug Conjugate
- China
apis: []
common:
- type: Website
  url: https://www.kelun-biotech.com
- type: Careers
  url: http://kelunbotai.zhiye.com/
- type: InvestorRelations
  url: https://www.kelun-biotech.com/news.aspx?mid=157
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence